U.S. market Closed. Opens in 11 hours 59 minutes

OMGA | Omega Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue3.09M2.07M144.00KN/AN/A
Cost of Revenue6.77M5.19M1.39M1.15M794.00K
Gross Profit-3.68M-3.12M-1.24M-1.15M-794.00K
Operating Expenses96.58M104.84M66.18M28.64M17.34M
Selling, General & Admin19.41M21.82M16.60M6.24M4.23M
Research & Development77.17M80.00M47.87M21.06M11.93M
Other Operating Expenses23.00K3.02M1.71M1.35M1.18M
Operating Income-100.26M-102.77M-66.03M-28.64M-17.34M
Other Expenses / Income2.83M65.00K-2.25M-802.00K-606.00K
Before Tax Income-97.43M-102.70M-68.28M-29.45M-17.95M
Income Tax Expenses6.60M-65.00K882.00K752.00K584.00K
Net Income-97.43M-102.64M-69.16M-30.20M-18.53M
Interest ExpensesN/A222.00K910.00K777.00K595.00K
Basic Shares Outstanding54.01M47.88M47.79M47.84M47.84M
Diluted Shares Outstanding54.01M47.88M47.79M47.84M47.84M
EBITDA-93.49M-102.77M-64.67M-27.52M-16.56M
EBITDA Margin-3,021.65%-4,957.36%-44,911.81%0.00%0.00%
EBIT-90.82M-102.48M-67.37M-28.67M-17.35M
EBIT Margin-2,935.52%-4,943.51%-46,784.72%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙